The drug candidate, BHV-4157, is in clinical trials at Baylor College of Medicine at 50+ centers nationwide.  Thanks to Ivanhoe producer Donna Parker, for interviewing Elizabeth McIngvale, Ph.D., an OCD patient and Baylor psychologist; and Eric Storch, Ph.D., Baylor investigator.  Thanks to  KPRC 2 News medical reporter Haley Hernandez for bringing the story to local viewers in Houston.